The new potential biomarker of progression and prognosis in pancreatic cancer
Background The research on the molecular pathology of pancreatic cancer (PCC) has not been in-depth enough, and there is a lack of comprehensive analysis of the transcriptomics and clinical characteristics of the disease to determine […]